Background Restarting direct oral anticoagulants (DOACs) after a serious bleeding event in patients with atrial fibrillation ...

Vitamin K-inhibiting anticoagulants, especially warfarin, have become standard treatment for reducing the incidence of strokes and systemic emboli in patients with nonvalvular atrial fibrillation ...

Original Article from The New England Journal of Medicine — Treatment of Nonvalvular Heart Disease of Middle and Old Age ...

Original Article from The New England Journal of Medicine — Diagnosis of Chronic Nonvalvular Cardiac Disease (Chronic Myocarditis) ...

We collected the clinical data of 144 underweight patients with nonvalvular atrial fibrillation (NVAF) treated with rivaroxaban in our hospital, to investigate the effect of different doses of ...

Multiple considerations come into play when choosing anticoagulant therapy for a patient with atrial fibrillation, a condition that greatly increases the risk for stroke.

Reduced left atrial appendage emptying velocity (LAAEV) is an important indicator of nonvalvular AF, associated with thrombosis and recurrence after catheter ablation. This study aims to identify ...

In patients with nonvalvular atrial fibrillation (NVAF), warfarin anticoagulation limits stroke risk better than aspirin does.

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

In patients with nonvalvular atrial fibrillation, several common cancer types are associated with increased stroke or bleeding risk. Common cancer types are associated with stroke and bleeding risks ...